Literature DB >> 19406915

Glomerular filtration rate is a confounder for the measurement of soluble mesothelin in serum.

Kevin Hollevoet, Dirk Bernard, Frank De Geeter, Natascha Walgraeve, Anja Van den Eeckhaut, Raymond Vanholder, Christophe Van de Wiele, Veronique Stove, Jan P van Meerbeeck, Joris R Delanghe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19406915     DOI： 10.1373/clinchem.2008.121913

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  8 in total

1.  Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.

Authors:  Mehmet Bayram; Isa Dongel; Ali Akbaş; Ismail Benli; Muhammed Emin Akkoyunlu; Nur Dilek Bakan
Journal:  Lung       Date:  2013-10-30       Impact factor: 2.584

2.  Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum.

Authors:  Daniel Gilbert Weber; Georg Johnen; Dirk Taeger; Anne Weber; Isabelle Mercedes Gross; Beate Pesch; Thomas Kraus; Thomas Brüning; Monika Gube
Journal:  Biomark Insights       Date:  2010-01-28

3.  Pleural fluid mesothelin as an adjunct to the diagnosis of pleural malignant mesothelioma.

Authors:  Jenette Creaney; Amanda Segal; Nola Olsen; Ian M Dick; A W Bill Musk; Steven J Skates; Bruce W Robinson
Journal:  Dis Markers       Date:  2014-11-23       Impact factor: 3.434

4.  Re-evaluation of potential predictors of calretinin and mesothelin in a population-based cohort study using assays for the routine application in clinical medicine.

Authors:  Swaantje Casjens; Georg Johnen; Irina Raiko; Beate Pesch; Dirk Taeger; Carmen Töpfer; Sandra Schonefeld; Susanne Moebus; Karl-Heinz Jöckel; Thomas Brüning; Daniel Weber
Journal:  BMJ Open       Date:  2021-02-18       Impact factor: 2.692

5.  Proteome screening of pleural effusions identifies galectin 1 as a diagnostic biomarker and highlights several prognostic biomarkers for malignant mesothelioma.

Authors:  Filip Mundt; Henrik J Johansson; Jenny Forshed; Sertaç Arslan; Muzaffer Metintas; Katalin Dobra; Janne Lehtiö; Anders Hjerpe
Journal:  Mol Cell Proteomics       Date:  2013-12-20       Impact factor: 5.911

6.  Assessment of potential predictors of calretinin and mesothelin to improve the diagnostic performance to detect malignant mesothelioma: results from a population-based cohort study.

Authors:  Swaantje Casjens; Daniel G Weber; Georg Johnen; Irina Raiko; Dirk Taeger; Carmen Meinig; Susanne Moebus; Karl-Heinz Jöckel; Thomas Brüning; Beate Pesch
Journal:  BMJ Open       Date:  2017-10-11       Impact factor: 2.692

7.  Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers.

Authors:  Georg Johnen; Katarzyna Burek; Irina Raiko; Katharina Wichert; Beate Pesch; Daniel G Weber; Martin Lehnert; Swaantje Casjens; Olaf Hagemeyer; Dirk Taeger; Thomas Brüning
Journal:  Sci Rep       Date:  2018-09-25       Impact factor: 4.379

8.  Biomarkers for Predicting Malignant Pleural Mesothelioma in a Mexican Population.

Authors:  Guadalupe Aguilar-Madrid; Beate Pesch; Emma S Calderón-Aranda; Katarzyna Burek; Carmina Jiménez-Ramírez; Cuauhtémoc Arturo Juárez-Pérez; María Dolores Ochoa-Vázquez; Luis Torre-Bouscoulet; Leonor Concepción Acosta-Saavedra; Isabel Sada-Ovalle; Jorge García-Figueroa; Isabel Alvarado-Cabrero; Patricia Castillo-González; Alejandra Renata Báez-Saldaña; José Rogelio Pérez-Padilla; Juvencio Osnaya-Juárez; Rosa María Rivera-Rosales; Eric Marco García-Bazán; Yolanda Lizbeth Bautista-Aragón; Elimelec Lazcano-Hernandez; Daniel Alejandro Munguía-Canales; Luis Marcelo Argote-Greene; Dirk Taeger; Daniel Gilbert Weber; Swaantje Casjens; Irina Raiko; Thomas Brüning; Georg Johnen
Journal:  Int J Med Sci       Date:  2018-06-04       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.